BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2283606)

  • 1. Six-month combination chemotherapy for cervical tuberculous lymphadenitis.
    Cheung WL; Siu KF; Ng A
    J R Coll Surg Edinb; 1990 Oct; 35(5):293-5. PubMed ID: 2283606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short course chemotherapy for tuberculosis of lymph nodes.
    Gajanan SG
    Natl Med J India; 1994; 7(3):125-6. PubMed ID: 8069204
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of tuberculous masses in the neck.
    Deitel M; Saldanha CF; Borowy ZJ; Ronald AC; Krajden S
    Can J Surg; 1984 Jan; 27(1):90-3. PubMed ID: 6467109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A controlled survey comparing 2 short-term therapeutic regimes in lymph node tuberculosis].
    Amrane R; Mazouni L; Boulahbal F; Abtroun N; Zidane C
    Rev Mal Respir; 1989; 6(1):53-7. PubMed ID: 2648510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of INH-rifampicin treatment of lymph node tuberculosis].
    Weinecke A
    Z Erkr Atmungsorgane; 1989; 173(1):63-7. PubMed ID: 2800617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of cytomorphology of tuberculous lymphadenitis and changes during anti-tubercular treatment.
    Sharma M; Agarwal S; Wadhwa N; Mishra K; Gadre DJ
    Cytopathology; 2007 Jun; 18(3):180-3. PubMed ID: 17388932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data].
    Iukhimenko NV
    Probl Tuberk; 2001; (5):19-22. PubMed ID: 11588952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
    Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up results in tuberculous cervical lymphadenitis.
    Oktay MF; Topcu I; Senyigit A; Bilici A; Arslan A; Cureoglu S; Yildirim M
    J Laryngol Otol; 2006 Feb; 120(2):129-32. PubMed ID: 16359138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cervical tuberculous lymphadenitis: the location of surgery].
    Benmansour N; Oudidi A; El Alami MN
    J Otolaryngol Head Neck Surg; 2009 Feb; 38(1):23-8. PubMed ID: 19344609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of tuberculous meningitis: role of short-course chemotherapy.
    Phuapradit P; Vejjajiva A
    Q J Med; 1987 Mar; 62(239):249-58. PubMed ID: 3659258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short course chemotherapy for tuberculous lymphadenitis in children.
    Jawahar MS; Sivasubramanian S; Vijayan VK; Ramakrishnan CV; Paramasivan CN; Selvakumar V; Paul S; Tripathy SP; Prabhakar R
    BMJ; 1990 Aug 18-25; 301(6748):359-62. PubMed ID: 2205318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.